Google News Alert for: blood pressure
| Gilead Sciences' Phase III Darusentan Data Show Significant Blood ... WELT ONLINE - Berlin,Berlin,Germany The co-primary efficacy endpoints were change from baseline to week 14 in trough sitting systolic blood pressure (SBP) and trough sitting diastolic blood ... See all stories on this topic |
This as-it-happens Google Alert is brought to you by Google.
Create another alert.
Manage your alerts.
No comments:
Post a Comment